Alzheimer’s disease. It’s the holy grail of pharmaceutical research, and on May 11, a team of physicians published results showing that they may have found the key to actually improving cognition in patients with early-stage dementia.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,